04.01.21
Roche's Evrysdi wins EU approval for spinal muscular atrophy
FILE PHOTO: A sign at a diagnostics site for Swiss pharmaceutical giant Roche is seen, in Burgess Hill, Britain, October 7, 2020. REUTERS/Peter NichollsZURICH (Reuters) – Roche’s Evrysdi has won approval from the European Commission as the first and only at-home treatment for spinal muscular atrophy (SMA), the Swiss drugmaker said on Tuesday. It has